Carboxymethylcellulose‐stabilized collagenous rhOP‐1 device—a novel carrier biomaterial for the repair of mandibular continuity defects
- 10 December 2003
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 68A (2) , 219-226
- https://doi.org/10.1002/jbm.a.10129
Abstract
Human recombinant osteogenic protein‐1 (rhOP‐1) is osteoinductive. Efforts are made to develop carrier biomaterials with improved space‐keeping properties. Bovine collagen type I matrix charged with rhOP‐1 was suggested to be an advantageous device of relative liquid quality. We hypothesized that the addition of carboxymethylcellulose (CMC) may stabilize the device and facilitate the regeneration of mandibular continuity defects without further addition of mineralized carrier materials. To test this hypothesis, the anatomical shape, functional remodeling, and mechanical stability of such bony regenerates were evaluated in the course of an animal experiment. Mandibular continuity defects of 5 cm in size were created in five Göttingen minipigs on one side (contralateral hemimandible: control) and bridged with titanium plates. Four animals were treated with the rhOP‐1 device (3000 μg rhOP‐1, 2 g collagen, 1 g CMC), and one animal was treated with a placebo device omitting rhOP‐1. After 12 weeks of experimental period, bony continuity was reestablished in rhOP‐1‐treated hemimandibles. The bony regenerates were of good anatomical shape, volume, and functional remodeling. Placebo treatment led to insufficient bony regenerates of significant lower bone volume (volume in 3D‐CT scan 29.81 cm3 vs 8.85 cm3). To produce 1 mm of bending, 1972 N were needed for rhOP‐1‐treated hemimandibles, 2617 N for control hemimandibles, and 642 N for the placebo treated hemimandible. CMC stabilization of collagen carrier biomaterials for rhOP‐1 provides good plasticity as well as excellent space‐keeping properties and may not interfere with osteoinduction. The results of this preliminary study suggest that the applied rhOP‐1 device offers a potential option for further studies on the reconstruction of mandibular defects. © 2003 Wiley Periodicals, Inc. J Biomed Mater Res 68A: 219–226, 2004Keywords
This publication has 28 references indexed in Scilit:
- Effects of bone morphogenetic protein‐7 stimulation on osteoblasts cultured on different biomaterialsJournal of Cellular Biochemistry, 2002
- Sinusbodenaugmentation mit simultaner Implantatinsertion unter Verwendung von rekombinantem humanem Osteogenic Protein-112Laryngo-Rhino-Otologie, 2001
- Sinus floor augmentation with simultaneous placement of dental implants using a combination of deproteinized bone xenografts and recombinant human osteogenic protein‐l. A histometric study in miniature pigs.Clinical Oral Implants Research, 1999
- Mandibular reconstruction in miniature pigs with prefabricated vascularized bone grafts using recmombinant human osteogenic protein-1: a preliminary studyInternational Journal of Oral & Maxillofacial Surgery, 1999
- Evaluation of the long-term effect of function on rhBMP-2 regenerated hemimandibulectomy defectsBritish Journal of Oral and Maxillofacial Surgery, 1999
- Mandibular Reconstruction Using Bone Morphogenetic ProteinLong‐Term Follow‐up in a Canine ModelThe Laryngoscope, 1999
- The Mechanism of Autoantibody Formation to Cartilage in Rheumatoid Arthritis: Possible Cross-Reaction of Antibodies to Dietary Collagens with Autologous Type II CollagenClinical Immunology and Immunopathology, 1996
- Complete Regeneration of Bone in the Baboon by Recombinant Human Osteogenic Protein-1 (hOP-1, Bone Morphogenetic Protein-7)Growth Factors, 1996
- Healing of experimentally created defects: a reviewBritish Journal of Oral and Maxillofacial Surgery, 1995